Compare PCRX & FLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PCRX | FLO |
|---|---|---|
| Founded | 2006 | 1919 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.2B |
| IPO Year | 2010 | 2000 |
| Metric | PCRX | FLO |
|---|---|---|
| Price | $36.48 | $5.24 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 9 | 5 |
| Target Price | ★ $33.57 | $7.00 |
| AVG Volume (30 Days) | 958.5K | ★ 6.4M |
| Earning Date | 11-09-2026 | 11-12-2026 |
| Dividend Yield | N/A | ★ 9.04% |
| EPS Growth | ★ 107.44 | N/A |
| EPS | ★ 0.89 | 0.46 |
| Revenue | $541,533,000.00 | ★ $5,256,479,000.00 |
| Revenue This Year | $3.84 | N/A |
| Revenue Next Year | $4.73 | N/A |
| P/E Ratio | $40.96 | ★ $11.90 |
| Revenue Growth | ★ 26.04 | 3.00 |
| 52 Week Low | $18.80 | $5.31 |
| 52 Week High | $36.67 | $12.09 |
| Indicator | PCRX | FLO |
|---|---|---|
| Relative Strength Index (RSI) | 82.40 | 31.30 |
| Support Level | $22.00 | N/A |
| Resistance Level | $36.67 | $8.93 |
| Average True Range (ATR) | 0.04 | 0.36 |
| MACD | -0.37 | -0.15 |
| Stochastic Oscillator | 90.00 | 1.20 |
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
Flowers Foods Inc operates as a producer and marketer of packaged bakery foods in the United States. Its principal products include breads, buns, rolls, snack items (bars, cakes, cookies, and crackers), bagels, English muffins, tortillas, and baking mixes. These products are sold under the brand names Nature's Own, Dave's Killer Bread (DKB), Canyon Bakehouse, Simple Mills, Wonder, and Tastykake. The company derives the majority of its revenue from the sales of its bakery products.